DERM (Journey Medical Corp) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan journeymedicalcorp.com (DERM)

Journey Medical (DERM) focuses on the production of proven dermatological drugs that guarantee a steady cash flow and high-quality earnings. The company is implementing advanced treatments for rosacea and acne, expanding its aesthetic presence through its distribution channels. The stock price tracked on the GURU.Markets chart is 4.28. Operations are protected by stable US law and an absence of trade restrictions, which minimizes external risks.

DERM journeymedicalcorp.com: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Journey Medical (DERM)

- rega lan prakiraan konsensus rega:
Bagan rega journeymedicalcorp.com|DERM - Target konsensus
- data kapitalisasi pasar:
Nilai pasar Journey Medical Corp.|DERM - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Journey Medical|DERM - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku journeymedicalcorp.com|DERM - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Journey Medical|DERM - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas journeymedicalcorp.com|DERM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Journey Medical Corp.|DERM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Journey Medical
Analisis wiwitan perusahaan:Journey Medical Corp - DERM
Produk asli journeymedicalcorp.com

The Journey Medical (DERM) production outsourcing model minimizes capital expenditures by shifting risks to vendors and optimizing the asset structure. By analyzing the market capitalization-to-book value ratio, an investor determines the premium paid for the business relative to its net value, separating speculative price growth from the issuer's actual fundamental stability on this chart.

Pesaing utama

KRYS (Krystal Biotech, Inc.) - Rasio Nilai Pasar marang Nilai Buku|APGE (apogeetherapeutics.com) - Rasio Kapitalisasi marang Aset Bersih|Rasio Nilai Pasar marang Nilai Buku Arcutis Biotherapeutics, Inc. ARQT|Kapitalisasi Pasar marang Aset Bersih Vericel Corp|Oruka Corp (ORKA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku sanaramedtech.com (SMTI)|Rasio Kapitalisasi Pasar marang Nilai Buku DBVT (DBV Technologies)|Solesence Beauty - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Forte Biosciences (FBRX)|EMPG: Nilai Pasar marang Nilai Buku|SLGL (Sol-Gel) - Rasio Nilai Pasar marang Nilai Buku|AXIL Brands (AXIL) - Rasio Kapitalisasi marang Aset Bersih|MDCX (Medicus Pharma Ltd.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Verrica (VRCA)|Hoth Therapeutics, Inc. (HOTH) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku BFRI (biofrontera-us.com)|Rasio Nilai Pasar marang Nilai Buku VYNE|Sonoma Pharmaceuticals Inc. - Kapitalisasi Pasar marang Nilai Buku|Quoin Pharma - Rasio Nilai Pasar marang Nilai Buku|AZTR - Rasio Kapitalisasi Pasar marang Nilai Buku|Dermata Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|ELAB (Elevai Labs Inc) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Revance Therapeutics, Inc (RVNC)